Email
IZ Express #1,642: Experts offer vaccination resources for the ongoing monkeypox outbreak, and more
| From | Immunize.org <[email protected]> |
| Subject | IZ Express #1,642: Experts offer vaccination resources for the ongoing monkeypox outbreak, and more |
| Date | July 13, 2022 11:15 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed]
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,642: July 13, 2022
Top Stories
* Experts offer vaccination resources for the ongoing monkeypox outbreak; CDC announces increased nationwide testing capacity
* American Academy of Pediatrics and the Children’s Hospital Association issue reports reviewing COVID-19 disease and vaccination trends
* National Adult and Influenza Immunization Summit solicits nominations for 2022 NAIIS Immunization Excellence Awards; deadline is July 25
* Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 560 institutions, including one new honoree. Five previously honored institutions qualify for sustained honors.
* Spotlight: Check out the Immunize.org resources to help with your vaccine advocacy
* Vaccines in the news
Featured Resources
* Montgomery County (Pennsylvania) Immunization Coalition releases COVID-19 vaccine resources in five languages for children age 6 months up to 5 years
* Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last!
* Immunize.org updates one line in “Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools” to include infants and young children
Notable Publications
* CDC publishes "Factors Associated with Severe Outcomes among Immunocompromised Adults Hospitalized for COVID-19—COVID-NET, 10 States, March 2020–February 2022" in MMWR
* "The Vaccine-Hesitant Moment" published in New England Journal of Medicine
* "Safety of COVID-19 Vaccination in U.S. Children Ages 5–11 Years" pre-published in Pediatrics
Upcoming Events
* Virtual: Today! NFID offers webinar “Updates from June 2022 Advisory Committee on Immunization Practices (ACIP) Meeting”; CME available.
Editorial Information
------------------------------------------------------------
Top Stories
------------------------------------------------------------
Experts offer vaccination resources for the ongoing monkeypox outbreak; CDC announces increased nationwide testing capacity
CDC is closely tracking cases of monkeypox detected in the United States during the 2022 monkeypox outbreak ([link removed]) . Anyone who has been in close contact with someone who has monkeypox is at risk. To date, gay, bisexual, and other men who have sex with men make up a high number of cases.
On July 6, CDC announced that Labcorp will begin testing for monkeypox ([link removed]) using CDC’s orthopoxvirus test (which detects all non-smallpox related orthopoxviruses, including monkeypox). CDC anticipates additional commercial laboratories ([link removed]) will come online in the coming days, and monkeypox testing capacity will continue to increase throughout the month of July. A portion of the press release appears below.
Labcorp will offer this testing at its largest facility in the United States and will be able to accept specimens from anywhere in the country. Labcorp expects to be able to perform up to 10,000 tests per week, which will double the current capacity provided through CDC’s Laboratory Response Network (LRN) ([link removed]), which itself has rapidly expanded testing capacity over the last seven weeks.
Bavarian Nordic, the manufacturer of Jynneos (Smallpox and Monkeypox Vaccine, Live, Nonreplicating), issued a letter to the CDC updating the cold-chain tolerances of this vaccine. Notably, unopen vials of Jynneos may be stored at 2 to 8°C for up to 8 weeks after thawing ([link removed]), longer than described in the Jynneos package insert.
The Association of State and Territorial Health Officials (ASTHO) released two educational podcasts: Podcast 197: Preparing for Monkeypox ([link removed]) and Podcast 211: Monkeypox Response ([link removed]).
The Council of State and Territorial Epidemiologists (CSTE) issued Position Statement 22-ID-10: Public Health Reporting and National Notification for Monkeypox Virus Infection ([link removed]).
CDC urges healthcare professionals to be alert for patients with a rash consistent with monkeypox regardless of their specific risk factors for monkeypox. Use these CDC resources to familiarize yourself with this disease and how it appears.
* 2022 Monkeypox: Information for Healthcare Professionals ([link removed])
* Monkeypox: Signs and Symptoms ([link removed])
* Monkeypox: How It Spreads ([link removed])
* Monkeypox: Prevention ([link removed])
* Infection Prevention and Control of Monkeypox in Healthcare Settings ([link removed])
At this time, CDC does not recommend widespread vaccination against monkeypox. However, vaccination may be recommended for some people who:
* Are in close personal contact with people who have monkeypox
* May have been exposed to the virus
* May have an increased risk of being exposed to the virus, such as people who perform laboratory testing to diagnose monkeypox
Related Links
* CDC: Monkeypox Vaccines: What You Need to Know ([link removed]) web page
* Immunize.org: Smallpox/Monkeypox VIS ([link removed]) main page
* Bavarian Nordic: BN-CDC-ASPR Jynneos Stability Letter ([link removed]) (6/14/22)
* Association of State and Territorial Health Officials (ASTHO): Podcast 197: Preparing for Monkeypox ([link removed]) and Podcast 211: Monkeypox Response ([link removed])
* Council of State and Territorial Epidemiologists (CSTE): Position Statement 22-ID-10: Public Health Reporting and National Notification for Monkeypox Virus Infection ([link removed])
------------------------------------------------------------
American Academy of Pediatrics and the Children’s Hospital Association issue reports reviewing COVID-19 disease and vaccination trends
Drawing on data collected and published by CDC, AAP analyzes progress in vaccinating U.S. children younger than age 18 years in a weekly summary report titled Children and COVID-19 Vaccinations Trends ([link removed]). The report covers the vaccine data available for children age 5–11 years, and the longer-term data for children age 12–17 years.
To download the full report with its useful graphics, click on the image below.
[link removed]
Additionally, AAP and the Children’s Hospital Association (CHA) are collaborating to collect and share all publicly available data in the Children and COVID-19: State-Level Data Report ([link removed]). AAP and CHA revise this report periodically. A portion of the report appears below.
Almost 13.8 million children are reported to have tested positive for COVID-19 since the onset of the pandemic according to available state reports; nearly 315,000 of these cases have been added in the past 4 weeks. Approximately 5.9 million reported cases have been added in 2022.
Related Links
* AAP: Children and COVID-19 Vaccinations Trends ([link removed]) report web page
* AAP: Children and COVID-19 Vaccinations Trends ([link removed]) full report (6/29/22)
* AAP/CHA: Children and COVID-19: State-Level Data Report ([link removed]) web page
* CDC: COVID Data Tracker ([link removed]) main page
------------------------------------------------------------
National Adult and Influenza Immunization Summit solicits nominations for 2022 NAIIS Immunization Excellence Awards; deadline is July 25
The National Adult and Influenza Immunization Summit ([link removed]) (NAIIS, alias "The Summit") is soliciting nominations for the 2022 NAIIS Immunization Excellence Awards ([link removed]) no later than July 25, 2022. Immunization stakeholders go above and beyond to serve the public health and healthcare needs of individuals and communities, and the Summit wants to recognize our heroes.
The NAIIS Immunization Excellence Awards recognize individuals and organizations that made contributions to influenza vaccination and adult vaccination during 2021–2022. Unless an award is specifically focused on influenza, the Summit seeks to recognize broader adult immunization activities. Of course, activities related to COVID-19 immunization are welcome.
* A national winner will be selected for each award category.
* Where appropriate, honorable mention recipients may be selected.
* The winners will receive their awards at the NAIIS in-person meeting (tentatively scheduled for November 2–3, 2022, in Atlanta, GA).
* The national winner in each category will be invited to give a brief talk about their programs at the NAIIS meeting.
Access the 2022 NAIIS Immunization Excellence Awards ([link removed]) nomination form.
------------------------------------------------------------
Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 560 institutions, including one new honoree. Five previously honored institutions qualify for sustained honors.
Immunize.org is pleased to announce acceptance of one new institution into its Hepatitis B Birth Dose Honor Roll ([link removed]), for a total of 560 honorees. The birthing institution is listed below with its reported hepatitis B birth dose coverage rate in parentheses.
* BayCare Morton Plant Hospital, Clearwater, FL (90%)
Several institutions are recognized for qualifying for an additional year:
AdventHealth Waterman, Tavares, FL 90% 3 years
St. Mary’s Healthcare, Amsterdam, NY 96% 3 years
Montefiore Wakefield, Bronx, NY 97% 4 years
Southern Maine Health Care, Biddeford, ME 97% 4 years
Montefiore New Rochelle, Bronx, NY 95% 9 years
The Honor Roll now includes 560 birthing institutions from 44 states, the District of Columbia, Puerto Rico, Guam, Saipan, and a U.S. military base in England.
The Honor Roll is a key part of Immunize.org’s major initiative urging the nation’s hospitals to Give Birth to the End of Hep B ([link removed]). Hospitals and birthing centers are recognized for attaining high coverage rates of hepatitis B vaccination at birth and meeting specific additional criteria. The initiative urges qualifying healthcare organizations to apply for the Hepatitis B Birth Dose Honor Roll online ([link removed]).
Qualifications: To be included in the Hepatitis B Birth Dose Honor Roll, a birthing institution must have: (1) reported a coverage rate of 90% or greater, over a 12-month period, for administering hepatitis B vaccine before hospital discharge to all newborns, including those whose parents refuse vaccination, and (2) implemented specific written policies, procedures, and protocols to protect all newborns from hepatitis B virus infection before hospital discharge.
Honorees are also awarded an 8.5" x 11" color certificate suitable for framing and their acceptance is announced to IZ Express’s 54,000+ readers.
Please visit the Hepatitis B Birth Dose Honor Roll web page ([link removed]) that lists these institutions and their exceptional efforts to protect infants from perinatal hepatitis B transmission.
Related Immunize.org Resources
* Give Birth to the End of Hep B ([link removed]) main page
* Fact sheet about honor roll: Do You Qualify for the Hepatitis B Birth Dose Honor Roll? If So, Apply Today. ([link removed])
* Handout on Immunize.org’s campaign: Give Birth to the End of Hep B ([link removed])
* Hepatitis B Birth Dose Honor Roll ([link removed]) web page
------------------------------------------------------------
Spotlight: Check out the Immunize.org resources to help with your vaccine advocacy
Here are Immunize.org resources that can aid your vaccine advocacy efforts.
Our State Laws and Mandates by Vaccine ([link removed]) main page contains links to vaccine-specific requirements state-by-state for daycare, K-12, and post-secondary education settings. State-specific information about exemption policies is available as well.
Our State Exemptions ([link removed]) main page offers information on state mandates by vaccine-preventable disease. It includes policy statements from medical organizations endorsing strong school and childcare vaccination requirements and the elimination of non-medical exemptions.
Our State Information: Exemptions Permitted for State Immunization Requirements ([link removed]) web page shows which states allow medical, religious, and personal vaccination exemptions and offers a map of exemptions permitted for school and child care.
Our State Information: Direct Links to State Immunization Websites ([link removed]) main page offers links to each state's vaccination policy web page.
Our Talking about Vaccines ([link removed]) main page provides medical professionals with background information and practical resources divided into different topics that will help them discuss immunization with concerned parents or patients.
Our Unprotected People Stories ([link removed]) main page features 109 real-life accounts of people who have suffered or died from vaccine-preventable diseases: compelling personal testimonies, remembrances, case reports, and newspaper articles.
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* ABC: About 300,000 Kids under 5 Have Gotten at Least 1 Dose of COVID Vaccine So Far ([link removed]) (7/7/22)
* New York Times: First American to Get COVID Vaccine Is Awarded Medal of Freedom ([link removed]) (7/7/22)
* Forbes: ‘All-In-One’ Vaccine Could Protect against Future COVID-19 Variants, Researchers Say ([link removed]) (7/5/22)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Montgomery County (Pennsylvania) Immunization Coalition releases COVID-19 vaccine resources in five languages for children age 6 months up to 5 years
The Montgomery County (Pennsylvania) Immunization Coalition ([link removed]) (MCIC), in collaboration with trusted county, state, and private-sector partners, is distributing COVID-19 vaccine resources for children age 6 months up to 5 years. Resources include social media images and sample posts in multiple languages to provide clear, accurate, and culturally appropriate messages to the community.
Images can be found in Chinese ([link removed]), English ([link removed]), Hindi ([link removed]), Korean ([link removed]), and Spanish ([link removed]).
The images can also be found along with the social media posts in MCIC's AmVAXador Library ([link removed]). Feel free to share with your networks.
Related Link
* MCIC: COVID-19 Vaccine Virtual Town Hall: Children under 5 Years Old ([link removed]) webinar at 7:00 p.m. (ET) on July 31
------------------------------------------------------------
Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last!
Immunize.org's personal immunization record cards ([link removed]) , printed on rip-proof, smudge-proof, water-proof paper, are designed to last a lifetime. They fit in a wallet when folded. Give the record cards to your patients as a permanent personal vaccination record.
* Child & Teen Immunization Record Card ([link removed])
* Adult Immunization Record Card ([link removed])
* Lifetime Immunization Record Card ([link removed])
[link removed]
They are sold in boxes of 250. Make bulk purchases and receive quantity discounts. For quotes on larger quantities or customizing, or to request sample cards, call 651-647-9009 or email [email protected].
------------------------------------------------------------
Immunize.org updates one line in “Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools” to include infants and young children
Immunize.org has revised one line in its four-page job aid, Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) . This list can help you keep up with changes to COVID-19 vaccine guidance and resources for all ages, now including CDC and FDA resources for the vaccination of infants and young children. This document is revised at least monthly; the current version is dated July 8, 2022.
The single change, on the first page, describes the identifying colors of the packaging for the Janssen COVID-19 Vaccine as having a blue vial cap and no label border.
Related Links
* Immunize.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize.org: Vaccines: COVID-19 ([link removed]) main page
* Immunize.org: Ask the Experts: COVID-19 ([link removed]) web page
* CDC: Interim Clinical Considerations providing a summary of use of COVID-19 vaccines in the United States ([link removed]) main page
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
CDC publishes "Factors Associated with Severe Outcomes among Immunocompromised Adults Hospitalized for COVID-19—COVID-NET, 10 States, March 2020–February 2022" in MMWR
CDC published Factors Associated with Severe Outcomes among Immunocompromised Adults Hospitalized for COVID-19—COVID-NET, 10 States, March 2020–February 2022 ([link removed]) on July 8 in MMWR. A portion of the article appears below.
During March 1, 2020–February 28, 2022, among a sample of 22,345 adults hospitalized for COVID-19, 12.2% were immunocompromised. Among unvaccinated patients, those with immunocompromise had higher odds of ICU admission (adjusted odds ratio [aOR] = 1.26…) and in-hospital death (aOR = 1.34…) than did nonimmunocompromised patients. Among vaccinated patients, those with immunocompromise had higher odds of ICU admission (aOR = 1.40…) and in-hospital death (aOR = 1.87…) than did nonimmunocompromised patients. During March 1, 2021–February 28, 2022, among nonimmunocompromised patients, patients who were vaccinated had lower odds of death (aOR = 0.58; 95% CI = 0.39–0.86) than did unvaccinated patients; among immunocompromised patients, odds of death between vaccinated and unvaccinated patients did not differ.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
"The Vaccine-Hesitant Moment" published in New England Journal of Medicine
In the June 29 issue, the New England Journal of Medicine published a review article, The Vaccine-Hesitant Moment ([link removed]). A portion of the conclusions section appears below.
Physicians and other health care providers are still among the most trusted persons when it comes to health care advice. The Wellcome Global Monitor surveyed people in 140 countries and found that 73% of the respondents said that they would trust a doctor or a nurse more than others; the percentage was 90% in the higher-income countries. Vaccine acceptance can increase, but health care providers need to offer support and encouragement and listen to what matters from the patient’s perspective. Equipping physicians with information on the nature and scope of circulating concerns in their communities may help them address such concerns in the clinic, while also informing appropriate interventions at the community level.
------------------------------------------------------------
"Safety of COVID-19 Vaccination in U.S. Children Ages 5–11 Years" pre-published in Pediatrics
In the May 18 issue, Pediatrics published Safety of COVID-19 Vaccination in U.S. Children Ages 5–11 Years ([link removed]). The conclusions section appears below.
Safety findings for BNT-162b2 vaccine from 3 U.S. monitoring systems in children ages 5–11 years show that most reported adverse events were mild and no safety signals were observed in active surveillance. VAERS reporting rates of myocarditis after dose 2 in this age group were substantially lower than those observed among adolescents ages 12–15 years.
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: Today! NFID offers webinar “Updates from June 2022 Advisory Committee on Immunization Practices (ACIP) Meeting"; CME available.
National Foundation for Infectious Diseases (NFID) will offer a webinar titled Updates from June 2022 Advisory Committee on Immunization Practices (ACIP) Meeting ([link removed]) on July 13 at 12:00 p.m. (ET).
During this program, William Schaffner, MD, medical director, NFID, and ACIP liaison, and Jessica R. MacNeil, MPH, ACIP deputy executive secretary, CDC, will discuss the latest updates regarding current U.S. vaccination recommendations for children, adolescents, and adults. Content will focus primarily on non-COVID-19-related topics.
To register, click here ([link removed]) . NFID designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CME Credit.
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Robin VanOss
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]*
==============================================
Unsubscribe [email protected] from this list:
[link removed]
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,642: July 13, 2022
Top Stories
* Experts offer vaccination resources for the ongoing monkeypox outbreak; CDC announces increased nationwide testing capacity
* American Academy of Pediatrics and the Children’s Hospital Association issue reports reviewing COVID-19 disease and vaccination trends
* National Adult and Influenza Immunization Summit solicits nominations for 2022 NAIIS Immunization Excellence Awards; deadline is July 25
* Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 560 institutions, including one new honoree. Five previously honored institutions qualify for sustained honors.
* Spotlight: Check out the Immunize.org resources to help with your vaccine advocacy
* Vaccines in the news
Featured Resources
* Montgomery County (Pennsylvania) Immunization Coalition releases COVID-19 vaccine resources in five languages for children age 6 months up to 5 years
* Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last!
* Immunize.org updates one line in “Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools” to include infants and young children
Notable Publications
* CDC publishes "Factors Associated with Severe Outcomes among Immunocompromised Adults Hospitalized for COVID-19—COVID-NET, 10 States, March 2020–February 2022" in MMWR
* "The Vaccine-Hesitant Moment" published in New England Journal of Medicine
* "Safety of COVID-19 Vaccination in U.S. Children Ages 5–11 Years" pre-published in Pediatrics
Upcoming Events
* Virtual: Today! NFID offers webinar “Updates from June 2022 Advisory Committee on Immunization Practices (ACIP) Meeting”; CME available.
Editorial Information
------------------------------------------------------------
Top Stories
------------------------------------------------------------
Experts offer vaccination resources for the ongoing monkeypox outbreak; CDC announces increased nationwide testing capacity
CDC is closely tracking cases of monkeypox detected in the United States during the 2022 monkeypox outbreak ([link removed]) . Anyone who has been in close contact with someone who has monkeypox is at risk. To date, gay, bisexual, and other men who have sex with men make up a high number of cases.
On July 6, CDC announced that Labcorp will begin testing for monkeypox ([link removed]) using CDC’s orthopoxvirus test (which detects all non-smallpox related orthopoxviruses, including monkeypox). CDC anticipates additional commercial laboratories ([link removed]) will come online in the coming days, and monkeypox testing capacity will continue to increase throughout the month of July. A portion of the press release appears below.
Labcorp will offer this testing at its largest facility in the United States and will be able to accept specimens from anywhere in the country. Labcorp expects to be able to perform up to 10,000 tests per week, which will double the current capacity provided through CDC’s Laboratory Response Network (LRN) ([link removed]), which itself has rapidly expanded testing capacity over the last seven weeks.
Bavarian Nordic, the manufacturer of Jynneos (Smallpox and Monkeypox Vaccine, Live, Nonreplicating), issued a letter to the CDC updating the cold-chain tolerances of this vaccine. Notably, unopen vials of Jynneos may be stored at 2 to 8°C for up to 8 weeks after thawing ([link removed]), longer than described in the Jynneos package insert.
The Association of State and Territorial Health Officials (ASTHO) released two educational podcasts: Podcast 197: Preparing for Monkeypox ([link removed]) and Podcast 211: Monkeypox Response ([link removed]).
The Council of State and Territorial Epidemiologists (CSTE) issued Position Statement 22-ID-10: Public Health Reporting and National Notification for Monkeypox Virus Infection ([link removed]).
CDC urges healthcare professionals to be alert for patients with a rash consistent with monkeypox regardless of their specific risk factors for monkeypox. Use these CDC resources to familiarize yourself with this disease and how it appears.
* 2022 Monkeypox: Information for Healthcare Professionals ([link removed])
* Monkeypox: Signs and Symptoms ([link removed])
* Monkeypox: How It Spreads ([link removed])
* Monkeypox: Prevention ([link removed])
* Infection Prevention and Control of Monkeypox in Healthcare Settings ([link removed])
At this time, CDC does not recommend widespread vaccination against monkeypox. However, vaccination may be recommended for some people who:
* Are in close personal contact with people who have monkeypox
* May have been exposed to the virus
* May have an increased risk of being exposed to the virus, such as people who perform laboratory testing to diagnose monkeypox
Related Links
* CDC: Monkeypox Vaccines: What You Need to Know ([link removed]) web page
* Immunize.org: Smallpox/Monkeypox VIS ([link removed]) main page
* Bavarian Nordic: BN-CDC-ASPR Jynneos Stability Letter ([link removed]) (6/14/22)
* Association of State and Territorial Health Officials (ASTHO): Podcast 197: Preparing for Monkeypox ([link removed]) and Podcast 211: Monkeypox Response ([link removed])
* Council of State and Territorial Epidemiologists (CSTE): Position Statement 22-ID-10: Public Health Reporting and National Notification for Monkeypox Virus Infection ([link removed])
------------------------------------------------------------
American Academy of Pediatrics and the Children’s Hospital Association issue reports reviewing COVID-19 disease and vaccination trends
Drawing on data collected and published by CDC, AAP analyzes progress in vaccinating U.S. children younger than age 18 years in a weekly summary report titled Children and COVID-19 Vaccinations Trends ([link removed]). The report covers the vaccine data available for children age 5–11 years, and the longer-term data for children age 12–17 years.
To download the full report with its useful graphics, click on the image below.
[link removed]
Additionally, AAP and the Children’s Hospital Association (CHA) are collaborating to collect and share all publicly available data in the Children and COVID-19: State-Level Data Report ([link removed]). AAP and CHA revise this report periodically. A portion of the report appears below.
Almost 13.8 million children are reported to have tested positive for COVID-19 since the onset of the pandemic according to available state reports; nearly 315,000 of these cases have been added in the past 4 weeks. Approximately 5.9 million reported cases have been added in 2022.
Related Links
* AAP: Children and COVID-19 Vaccinations Trends ([link removed]) report web page
* AAP: Children and COVID-19 Vaccinations Trends ([link removed]) full report (6/29/22)
* AAP/CHA: Children and COVID-19: State-Level Data Report ([link removed]) web page
* CDC: COVID Data Tracker ([link removed]) main page
------------------------------------------------------------
National Adult and Influenza Immunization Summit solicits nominations for 2022 NAIIS Immunization Excellence Awards; deadline is July 25
The National Adult and Influenza Immunization Summit ([link removed]) (NAIIS, alias "The Summit") is soliciting nominations for the 2022 NAIIS Immunization Excellence Awards ([link removed]) no later than July 25, 2022. Immunization stakeholders go above and beyond to serve the public health and healthcare needs of individuals and communities, and the Summit wants to recognize our heroes.
The NAIIS Immunization Excellence Awards recognize individuals and organizations that made contributions to influenza vaccination and adult vaccination during 2021–2022. Unless an award is specifically focused on influenza, the Summit seeks to recognize broader adult immunization activities. Of course, activities related to COVID-19 immunization are welcome.
* A national winner will be selected for each award category.
* Where appropriate, honorable mention recipients may be selected.
* The winners will receive their awards at the NAIIS in-person meeting (tentatively scheduled for November 2–3, 2022, in Atlanta, GA).
* The national winner in each category will be invited to give a brief talk about their programs at the NAIIS meeting.
Access the 2022 NAIIS Immunization Excellence Awards ([link removed]) nomination form.
------------------------------------------------------------
Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 560 institutions, including one new honoree. Five previously honored institutions qualify for sustained honors.
Immunize.org is pleased to announce acceptance of one new institution into its Hepatitis B Birth Dose Honor Roll ([link removed]), for a total of 560 honorees. The birthing institution is listed below with its reported hepatitis B birth dose coverage rate in parentheses.
* BayCare Morton Plant Hospital, Clearwater, FL (90%)
Several institutions are recognized for qualifying for an additional year:
AdventHealth Waterman, Tavares, FL 90% 3 years
St. Mary’s Healthcare, Amsterdam, NY 96% 3 years
Montefiore Wakefield, Bronx, NY 97% 4 years
Southern Maine Health Care, Biddeford, ME 97% 4 years
Montefiore New Rochelle, Bronx, NY 95% 9 years
The Honor Roll now includes 560 birthing institutions from 44 states, the District of Columbia, Puerto Rico, Guam, Saipan, and a U.S. military base in England.
The Honor Roll is a key part of Immunize.org’s major initiative urging the nation’s hospitals to Give Birth to the End of Hep B ([link removed]). Hospitals and birthing centers are recognized for attaining high coverage rates of hepatitis B vaccination at birth and meeting specific additional criteria. The initiative urges qualifying healthcare organizations to apply for the Hepatitis B Birth Dose Honor Roll online ([link removed]).
Qualifications: To be included in the Hepatitis B Birth Dose Honor Roll, a birthing institution must have: (1) reported a coverage rate of 90% or greater, over a 12-month period, for administering hepatitis B vaccine before hospital discharge to all newborns, including those whose parents refuse vaccination, and (2) implemented specific written policies, procedures, and protocols to protect all newborns from hepatitis B virus infection before hospital discharge.
Honorees are also awarded an 8.5" x 11" color certificate suitable for framing and their acceptance is announced to IZ Express’s 54,000+ readers.
Please visit the Hepatitis B Birth Dose Honor Roll web page ([link removed]) that lists these institutions and their exceptional efforts to protect infants from perinatal hepatitis B transmission.
Related Immunize.org Resources
* Give Birth to the End of Hep B ([link removed]) main page
* Fact sheet about honor roll: Do You Qualify for the Hepatitis B Birth Dose Honor Roll? If So, Apply Today. ([link removed])
* Handout on Immunize.org’s campaign: Give Birth to the End of Hep B ([link removed])
* Hepatitis B Birth Dose Honor Roll ([link removed]) web page
------------------------------------------------------------
Spotlight: Check out the Immunize.org resources to help with your vaccine advocacy
Here are Immunize.org resources that can aid your vaccine advocacy efforts.
Our State Laws and Mandates by Vaccine ([link removed]) main page contains links to vaccine-specific requirements state-by-state for daycare, K-12, and post-secondary education settings. State-specific information about exemption policies is available as well.
Our State Exemptions ([link removed]) main page offers information on state mandates by vaccine-preventable disease. It includes policy statements from medical organizations endorsing strong school and childcare vaccination requirements and the elimination of non-medical exemptions.
Our State Information: Exemptions Permitted for State Immunization Requirements ([link removed]) web page shows which states allow medical, religious, and personal vaccination exemptions and offers a map of exemptions permitted for school and child care.
Our State Information: Direct Links to State Immunization Websites ([link removed]) main page offers links to each state's vaccination policy web page.
Our Talking about Vaccines ([link removed]) main page provides medical professionals with background information and practical resources divided into different topics that will help them discuss immunization with concerned parents or patients.
Our Unprotected People Stories ([link removed]) main page features 109 real-life accounts of people who have suffered or died from vaccine-preventable diseases: compelling personal testimonies, remembrances, case reports, and newspaper articles.
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* ABC: About 300,000 Kids under 5 Have Gotten at Least 1 Dose of COVID Vaccine So Far ([link removed]) (7/7/22)
* New York Times: First American to Get COVID Vaccine Is Awarded Medal of Freedom ([link removed]) (7/7/22)
* Forbes: ‘All-In-One’ Vaccine Could Protect against Future COVID-19 Variants, Researchers Say ([link removed]) (7/5/22)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Montgomery County (Pennsylvania) Immunization Coalition releases COVID-19 vaccine resources in five languages for children age 6 months up to 5 years
The Montgomery County (Pennsylvania) Immunization Coalition ([link removed]) (MCIC), in collaboration with trusted county, state, and private-sector partners, is distributing COVID-19 vaccine resources for children age 6 months up to 5 years. Resources include social media images and sample posts in multiple languages to provide clear, accurate, and culturally appropriate messages to the community.
Images can be found in Chinese ([link removed]), English ([link removed]), Hindi ([link removed]), Korean ([link removed]), and Spanish ([link removed]).
The images can also be found along with the social media posts in MCIC's AmVAXador Library ([link removed]). Feel free to share with your networks.
Related Link
* MCIC: COVID-19 Vaccine Virtual Town Hall: Children under 5 Years Old ([link removed]) webinar at 7:00 p.m. (ET) on July 31
------------------------------------------------------------
Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last!
Immunize.org's personal immunization record cards ([link removed]) , printed on rip-proof, smudge-proof, water-proof paper, are designed to last a lifetime. They fit in a wallet when folded. Give the record cards to your patients as a permanent personal vaccination record.
* Child & Teen Immunization Record Card ([link removed])
* Adult Immunization Record Card ([link removed])
* Lifetime Immunization Record Card ([link removed])
[link removed]
They are sold in boxes of 250. Make bulk purchases and receive quantity discounts. For quotes on larger quantities or customizing, or to request sample cards, call 651-647-9009 or email [email protected].
------------------------------------------------------------
Immunize.org updates one line in “Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools” to include infants and young children
Immunize.org has revised one line in its four-page job aid, Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) . This list can help you keep up with changes to COVID-19 vaccine guidance and resources for all ages, now including CDC and FDA resources for the vaccination of infants and young children. This document is revised at least monthly; the current version is dated July 8, 2022.
The single change, on the first page, describes the identifying colors of the packaging for the Janssen COVID-19 Vaccine as having a blue vial cap and no label border.
Related Links
* Immunize.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize.org: Vaccines: COVID-19 ([link removed]) main page
* Immunize.org: Ask the Experts: COVID-19 ([link removed]) web page
* CDC: Interim Clinical Considerations providing a summary of use of COVID-19 vaccines in the United States ([link removed]) main page
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
CDC publishes "Factors Associated with Severe Outcomes among Immunocompromised Adults Hospitalized for COVID-19—COVID-NET, 10 States, March 2020–February 2022" in MMWR
CDC published Factors Associated with Severe Outcomes among Immunocompromised Adults Hospitalized for COVID-19—COVID-NET, 10 States, March 2020–February 2022 ([link removed]) on July 8 in MMWR. A portion of the article appears below.
During March 1, 2020–February 28, 2022, among a sample of 22,345 adults hospitalized for COVID-19, 12.2% were immunocompromised. Among unvaccinated patients, those with immunocompromise had higher odds of ICU admission (adjusted odds ratio [aOR] = 1.26…) and in-hospital death (aOR = 1.34…) than did nonimmunocompromised patients. Among vaccinated patients, those with immunocompromise had higher odds of ICU admission (aOR = 1.40…) and in-hospital death (aOR = 1.87…) than did nonimmunocompromised patients. During March 1, 2021–February 28, 2022, among nonimmunocompromised patients, patients who were vaccinated had lower odds of death (aOR = 0.58; 95% CI = 0.39–0.86) than did unvaccinated patients; among immunocompromised patients, odds of death between vaccinated and unvaccinated patients did not differ.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
"The Vaccine-Hesitant Moment" published in New England Journal of Medicine
In the June 29 issue, the New England Journal of Medicine published a review article, The Vaccine-Hesitant Moment ([link removed]). A portion of the conclusions section appears below.
Physicians and other health care providers are still among the most trusted persons when it comes to health care advice. The Wellcome Global Monitor surveyed people in 140 countries and found that 73% of the respondents said that they would trust a doctor or a nurse more than others; the percentage was 90% in the higher-income countries. Vaccine acceptance can increase, but health care providers need to offer support and encouragement and listen to what matters from the patient’s perspective. Equipping physicians with information on the nature and scope of circulating concerns in their communities may help them address such concerns in the clinic, while also informing appropriate interventions at the community level.
------------------------------------------------------------
"Safety of COVID-19 Vaccination in U.S. Children Ages 5–11 Years" pre-published in Pediatrics
In the May 18 issue, Pediatrics published Safety of COVID-19 Vaccination in U.S. Children Ages 5–11 Years ([link removed]). The conclusions section appears below.
Safety findings for BNT-162b2 vaccine from 3 U.S. monitoring systems in children ages 5–11 years show that most reported adverse events were mild and no safety signals were observed in active surveillance. VAERS reporting rates of myocarditis after dose 2 in this age group were substantially lower than those observed among adolescents ages 12–15 years.
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: Today! NFID offers webinar “Updates from June 2022 Advisory Committee on Immunization Practices (ACIP) Meeting"; CME available.
National Foundation for Infectious Diseases (NFID) will offer a webinar titled Updates from June 2022 Advisory Committee on Immunization Practices (ACIP) Meeting ([link removed]) on July 13 at 12:00 p.m. (ET).
During this program, William Schaffner, MD, medical director, NFID, and ACIP liaison, and Jessica R. MacNeil, MPH, ACIP deputy executive secretary, CDC, will discuss the latest updates regarding current U.S. vaccination recommendations for children, adolescents, and adults. Content will focus primarily on non-COVID-19-related topics.
To register, click here ([link removed]) . NFID designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CME Credit.
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Robin VanOss
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]*
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp